Work

Abstract PS2-09-14: When interception needs a second chance: ctDNA dynamics in ER+/HER2- advanced breast cancer treated with 1st line CDK4/6 inhibitors - Insights from the CICLADES study

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-09-14

Authors: V. Massard, M. Betz, A. Diallo, J. Salleron, A. M. Savoye, D. Spaeth, F. Clatot, P. Barthelemy, R. Longo, Y. Tazi, M. Gardner, A. Witz, J. Dardare, D. Bechet, J. L. Merlin, A. Harlé

Institutions: Institut de Cancérologie de Lorraine, Institut Jean Godinot, Centre Henri Becquerel, Institut de Cancérologie Strasbourg, Centre Hospitalier Régional de Metz-Thionville, Hôpital Clinique Claude-Bernard

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130717066

Cites:

Cited by:

Related to: